The brains behind the BAD

Article

Drs Belin and Ambrosio's Enhanced Ectasia module is a keratoconus index, based on pachy

The early detection of ectatic change is of paramount importance to the refractive surgeon. Anterior curvature and ultrasonic pachymetry, alone, does not provide enough information to detect early corneal disease. The combination of anterior and posterior elevation and complete pachymetric data gives the clinician a more complete view of the structure of the cornea and allows for more effective screening. The OCULUS Pentacam's Scheimpflug Cross-sectional imaging (OCULUS Optikgerate GmbH, Wetzlar, Germany) provides for a three-dimensional reconstruction of the anterior segment, making possible the assessment of the anterior and posterior corneal surfaces and the creation of a complete pachymetric map. The Belin / Ambrósio Enhanced Ectasia Display (BAD display) was designed to utilise the data supplied by the Pentacam's rotating Scheimpflug camera and provide a comprehensive keratoconus screening display. The display combines the anterior and posterior elevation and pachymetric data into one all-inclusive display giving the clinician a more complete overview of the corneal shape and allowing for quick and effective screening of refractive surgery patients.

Recent Videos
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Dr Richard Lindstrom, Chairman of Surface Ophthalmics and founder of Minnesota Eye Consultants, speaks about ASCRS
© 2024 MJH Life Sciences

All rights reserved.